Recombinant multi-species IGFALS protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine IGFALS protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a serum protein that binds insulin-like growth factors, increasing their half-life and their vascular localization. Production of the encoded protein, which contains twenty leucine-rich repeats, is stimulated by growth hormone. Defects in this gene are a cause of acid-labile subunit deficiency, which maifests itself in a delayed and slow puberty. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]
The Alternative Names of target: ACLSD,ALS,Albs,Als,IGFALS,Igfals,Insulin-like growth factor-binding protein complex acid labile subunit

Target products collectionGo to IGFALS products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE0279-Ag-1/ GM-Tg-hg-SE0279-Ag-2 Human IGFALS protein Human
GM-Tg-rg-SE0279-Ag-1/ GM-Tg-rg-SE0279-Ag-2 Rat IGFALS protein Rat
GM-Tg-mg-SE0279-Ag-1/ GM-Tg-mg-SE0279-Ag-2 Mouse IGFALS protein Mouse
GM-Tg-cynog-SE0279-Ag-1/ GM-Tg-cynog-SE0279-Ag-2 Cynomolgus/Rhesus macaque IGFALS protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE0279-Ag-1/ GM-Tg-felg-SE0279-Ag-2 Feline IGFALS protein Feline
GM-Tg-cang-SE0279-Ag-1/ GM-Tg-cang-SE0279-Ag-2 Canine IGFALS protein Canine
GM-Tg-bovg-SE0279-Ag-1/ GM-Tg-bovg-SE0279-Ag-2 Bovine IGFALS protein Bovine
GM-Tg-equg-SE0279-Ag-1/ GM-Tg-equg-SE0279-Ag-2 Equine IGFALS protein Equine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE0279-Ag-1/ GM-Tg-hg-SE0279-Ag-2; GM-Tg-rg-SE0279-Ag-1/ GM-Tg-rg-SE0279-Ag-2;
GM-Tg-mg-SE0279-Ag-1/ GM-Tg-mg-SE0279-Ag-2; GM-Tg-cynog-SE0279-Ag-1/ GM-Tg-cynog-SE0279-Ag-2;
GM-Tg-felg-SE0279-Ag-1/ GM-Tg-felg-SE0279-Ag-2; GM-Tg-cang-SE0279-Ag-1/ GM-Tg-cang-SE0279-Ag-2;
GM-Tg-bovg-SE0279-Ag-1/ GM-Tg-bovg-SE0279-Ag-2; GM-Tg-equg-SE0279-Ag-1/ GM-Tg-equg-SE0279-Ag-2
Products Name IGFALS protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name IGFALS
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine IGFALS protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.